经颈静脉肝内门体分流术应用的回顾与展望

牛猛; 孙骏; 徐克; 钟红珊

doi:10.3969/j.issn.1001-5256.2016.02.005

经颈静脉肝内门体分流术应用的回顾与展望

DOI: 10.3969/j.issn.1001-5256.2016.02.005

中国医科大学附属第一医院介入科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2810
- HTML全文浏览量: 19
- PDF下载量: 482
- 被引次数: 0
出版历程
- 收稿日期: 2015-11-25
- 出版日期: 2016-02-20

Retrospects and prospects of transjugular intrahepatic portosystemic shunt in China

Department of Interventional Radiology,The First Affiliated Hospital of China Medical University

摘要

摘要: 近年来,经颈静脉肝内门体分流术(TIPS)在国内逐步推广并得到广泛认可,此项技术的技术标准、适应证和禁忌证也逐步建立。覆膜支架的诞生成功解决了裸支架分流道闭塞率高的问题,使TIPS迎来了另一个春天。遗憾的是,大多数临床研究发表于覆膜支架前,因此TIPS的临床疗效并不代表本领域的目前状态。随着此项技术的发展,TIPS正不断扩大其适应证,中国作为TIPS大国也急需更多高质量的多中心临床随机对照试验。TIPS在治疗门静脉高压症和肝血管疾病的各种并发症中,取得了越来越多的认可,并必将迎来一个美好的未来。
- 门静脉高压 /
- 门体分流术,经颈静脉肝内 /
- 食管和胃静脉曲张
Abstract: In recent years,transjugular intrahepatic portosystemic shunt( TIPS) has been gradually applied and widely accepted in China,and the technical standards,indications,and contraindications of this technique have also been established gradually. The invention of covered stents successfully solved the issue of a high rate of shunt occlusion seen in bare stents,and thus TIPS is greatly developed. Unfortunately,since most clinical studies were published before the invention of covered stents,the clinical effect of TIPS cannot represent the current status in this field. With the development of this technique,the indications for TIPS are gradually expanded,and as a country with many patients in need of TIPS,high- quality multicenter randomized controlled clinical trials are urgently needed in China. TIPS has been accepted in the treatment of various complications of portal hypertension and hepatic vascular diseases and will enjoy a promising future.
- portal hypertension /
- portasystemic shunt,transjugular intrahepatic /
- esophageal and gastric varices

HTML全文

参考文献(30)

[1] ROSCH J,HANAFEE W,SNOW H.Transjugular portal venography and radiologic,portacaval shunt:an experimental study[J].Radiology,1969,92(5):1112-1114.

[2]RICHTER GM,PALMAZ JC,NLDGE G.Der transjugulre intrahepatische portosystemische stent-shunt(TIPSS)eine neue nichtoperative,perkutane methode[J].Der Radiologe,1989,29:406-411.

[3]SAAD WE.The history and future of transjugular intrahepatic portosystemic shunt:food for thought[J].Semin Intervent Radiol,2014,31(3):258-261.

[4]XU K,ZHANG HG,HE FX,et al.Preliminary report on portal hypertention in liver cirrhosis treated by transjugular intrahepatic portosystemic stent shunt(analysis of 8 cases)[J].Chin J Radiol,1993,27(5):294-297.(in Chinese)徐克,张汉国,何芳显,等.经颈静脉肝内门腔静脉内支架分流术治疗肝硬变门脉高压症[J].中华放射学杂志,1993,27(5):294-297.

[5]ZHANG JS,WANG MQ,YANG L,et al.Transjugular intrahepatic portosystemic stent shunt stent shunts:early clinical experience[J].Chin J Med Imaging,1993,1(1):33-36.(in Chinese)张金山,王茂强,杨立,等.经颈静脉肝内门体静脉分流术应用疗效观察[J].中国医学影像学杂志,1993,1(1):33-36.

[6]RSSLE M,SIEGERSTETTER V,HUBER M,et al.The first decade of the transjugular intrahepatic portosystemic shunt(TIPS):state of the art[J].Liver,1998,18(2):73-89.

[7]ZHENG M,CHEN Y,BAI J,et al.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients:meta-analysis update[J].J Clin Gastroenterol,2008,42(5):507-516.

[8]BURROUGHS AK,VANGELI M.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy:randomized trials for secondary prophylaxis of variceal bleeding:an updated meta-analysis[J].Scand J Gastroenterol,2002,37(3):249-252.

[9]TENG GJ,BETTMANN AB,HOOPES PJ,et al.Effect of bile on smooth muscles cell proliferation in TIPS[J].Radiology,1998,208(3):799-805.

[10]LU Q,TENG GJ.Bile leakage in transjugular intrahepatic portosystemic shunt:effect on growth and function of endothelium[J].Chin J Radiol,2002,36(8):698-701.(in Chinese)卢勤,滕皋军.经颈静脉肝内门腔静脉分流术中胆汁漏出对内皮细胞生长及功能的影响[J].中华放射学杂志,2002,36(8):698-701.

[11]MURAD SD,LUONG TK,PATTYNAMA PMT,et al.Long-term outcome of a covered vs.uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome[J].Liver Int,2008,28(2):249-256.

[12]YANG Z,HAN G,WU Q,et al.Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents:a meta-analysis[J].J Gastroenterol Hepatol,2010,25(11):1718-1725.

[13]BAO YJ,GU JP,REN WX.The application of the Fluency covered stents in current clinical practice of TIPS[J].J Intervent Radiol,2014,23(4):357-359.鲍应军,顾俊鹏,任伟新.Fluency覆膜支架在TIPS中的应用现状[J].介入放射学杂志,2014,23(4):357-359.

[14]PERARNAU JM,Le GOUGE A,NICOLAS C,et al.Covered vs.uncovered stents for transjugular intrahepatic portosystemic shunt:a randomized controlled trial[J].J Hepatol,2014,60(5):962-968.

[15]PETERSEN B,BINKERT C.Intravascular ultrasound-guided direct intrahepatic portacaval shunt:midterm follow-up[J].J Vasc Interv Radiol,2004,15(9):927-938.

[16]PETERSEN BD,CLARK TW.Direct intrahepatic portocaval shunt[J].Tech Vasc Interv Radiol,2008,11(4):230-234.

[17] GARCIA-PAGN JC,CACA K,BUREAU C,et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].N Enql J Med,2010,362(25):2370-2379.

[18]TRIPATHI D,THERAPONDOS G,JACKSON E,et al.The role of the transjugular intrahepatic portosystemic stent shunt(TIPSS)in the management of bleeding gastric varices:clinical and haemodynamic correlations[J].Gut,2002,51(2):270-274.

[19]BARANGE K,PRON JM,IMANI K,et al.Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices[J].Hepatology,1999,30(5):1139-1143.

[20]HENDERSON JM,BOYER TD,KUTNER MH,et al.Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding:a randomized trial[J].Gastroenterology,2006,130(6):1643-1651.

[21]SALERNO F,CAMMC,ENEA M,et al.Transjugular intrahepatic portosystemic shunt for refractory ascites:a meta-analysis of individual patient data[J],Gastroenterology,2007,133(3):825-834.

[22]DHANASEKARAN R,WEST JK,GONZALES PC,et al.Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis[J].Am J Gastroenterol,2010,105(3):635-641.

[23]VALLA DC.Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome[J].Gut,2008,57(10):1469-1478.

[24]GARCIA-PAGN JC,HEYDTMANN M,RAFFA S,et al.TIPS for Budd-Chiari syndrome:long-term results and prognostics factors in124 patients[J].Gastroenterology,2008,135(3):808-815.

[25]QI X,GUO W,HE C,et al.Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome:techniques,indications and results on 51 Chinese patients from a single centre[J].Liver Int,2014,34(8):1164-1175.

[26]QI X,HAN G,YIN Z,et al.Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients[J].Dig Dis Sci,2012,57(4):1072-1082.

[27]BETTINGER D,KNPPEL E,EURINGER W,et al.Efficacy and safety of transjugular intrahepatic portosystemic shunt(TIPSS)in40 patients with hepatocellular carcinoma[J].Aliment Pharmacol Ther,2015,41(1):126-136.

[28]CONN HO.Transjugular intrahepatic portal-systemic shunts:the state of the art[J].Hepatology,1993,17(1):148-158.

[29]WALSER EM,NcN EES SW,DeL a PENA O,et al.Portal venous thrombosis:percutaneous therapy and outcome[J].J Vasc Interv Radiol,1998,9(1 Pt 1):119-127.

[30]HAN GH,MENG XJ,YIN ZX,et al.Percutaneous transsplenic portal catheterization combined with TIPS for the treatment of portal vein thrombosis associated with cavernous transformation[J].J Intervent Radiol,2009,18(3):177-181.韩国宏,孟祥杰,殷占新,等.经皮脾静脉途径联合TIPS治疗伴海绵样变性的门静脉血栓[J].介入放射学杂志,2009,18(3):177-181.

施引文献

资源附件(0)

访问统计